Table 3 Demographic characteristics and peripapillary RNFL thickness of the FMF and healthy control groups by colchicine dosage
Variables | Healthy Control Group (n = 32) | < 1.5 mg/day (n = 21) | ≥ 1.5 mg/day (n = 20) | Kruskal-Wallis test |
|---|---|---|---|---|
Age (years) (mean ± SD) | 34.72 ± 9.07 | 37.66 ± 11.67 | 35.35 ± 10.38 | p = 0.746 |
Gender (male/female) | 10/22 | 5/16 | 8/12 | p = 0.543 |
Mean RNFL (μm) (mean ± SD) | 98.18 ± 1.89 | 102.90 ± 7.32 | 99.85 ± 9.42 | p = 0.150 |
Superior RNFL (μm) (mean ± SD) | 117.04 ± 2.21 | 115.23 ± 8.96 | 116.30 ± 11.20 | p = 0.405 |
Inferior RNFL (μm) (mean ± SD) | 123.72 ± 2.84 | 130.04 ± 11.52 | 125.95 ± 12.70 | p = 0.148 |
Temporal RNFL (μm) (mean ± SD) | 70.45 ± 6.32 | 74.52 ± 11.58 | 71.10 ± 9.97 | p = 0.363 |
Nasal RNFL (μm) (mean ± SD) | 81.27 ± 4.16 | 87.76 ± 10.22 | 84.40 ± 14.17 | p = 0.145 |